CAR T-cell remedy is used to deal with sufferers with blood cancers comparable to a number of myeloma. Since it may well trigger severe unwanted side effects, sufferers are normally hospitalized and monitored for as much as two weeks after remedy. With remedies typically solely supplied at massive most cancers facilities, they are often tough to entry for a lot of sufferers. Be part of Dr. Sridevi Rajeeve, Myeloma and Cell Remedy Oncologist at Memorial Sloan Kettering Most cancers Heart, and Todd Greenwood, Senior Director of Proof and Outcomes at ZS Associates, as they talk about how wearable distant affected person monitoring gadgets might change the best way this remedy is obtainable.
You’ll be taught extra about:
- CAR T-cell remedy dangers and the challenges offered by the standard method the remedy is obtainable
- Outcomes of medical trials performed utilizing wearable distant affected person monitoring gadgets
- How distant affected person monitoring might make CAR T-cell remedy extra accessible and cost-effective